Sign in

CIK 0001789972

  • Non-accelerated filer
  • Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813879991
Phone
+1 617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Grant or award Chief Development Officer acquired 1,620 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 1,451 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 1,620 shares (grant or award)
  4. 4 Exercise or conversion 10% owner acquired 140,374 shares (option exercise)
  5. 4 Open-market sale 10% owner sold 101,903 shares at an average $12.80 ($1,304,816)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy President and CEO bought 8,090 shares at $12.40 ($100,316)
  11. 4 Open-market buy 10% owner bought 751,396 shares at $11.00 ($8,264,905)
  12. 4 Open-market sale 10% owner sold 418,738 shares at an average $9.66 ($4,045,791)
  13. 4 Open-market buy 10% owner bought 1,109,900 shares at an average $9.07 ($10,063,937)
  14. 4 Open-market buy 10% owner bought 276,000 shares at $10.75 ($2,966,972)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 13 · 253 filings